论文信息 - Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116). - 字舞流文

Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116).

E. Eisenhauer | A. Oza | K. Swenerton | M. Carey | L. McIntosh | L. Elit | W. Faught | P. Ghatage | A. Dorr | J. Holmlund | L. Mcintosh